FDA Warning Letter to Balkanica LLC (2026-06-29) — Foreign Supplier Verification Program (FSVP)
Letter issued · posted to fda.gov .
Subject as published: Foreign Supplier Verification Program (FSVP)
TL;DR
Key takeaway: The FDA issued a warning letter (CMS# 732478) to Balkanica LLC on June 29, 2026, following an inspection on May 20, 2026, for violations of the Foreign Supplier Verification Program (FSVP) regulation under 21 CFR part 1, subpart L. The agency found that Balkanica LLC failed to develop, maintain, and follow an FSVP for imported foods including sunflower seeds from Iadki Detelina Ltd. (Bulgaria) and sheep's milk cheese from Makler Komers LTD. (Bulgaria). The FDA requested a written response within 15 working days with documentation of corrective actions and warned that non-compliance may result in detention without physical examination (DWPE) of imported foods or refusal of admission.
Argus analysis
# FDA Warning Letter Analysis: Balkanica LLC
**Company and Findings**
Balkanica LLC, a food importer located in Clifton, New Jersey, received a warning letter from the FDA's Office of Inspections and Investigations on June 29, 2026, following an inspection conducted May 20, 2026. The company imports sunflower seeds from Bulgaria (Iadki Detelina Ltd.) and sheep's milk cheese (Balkan Dairy, via Makler Komers LTD.). FDA inspections on three occasions—July 2023, October 2024, and May 2026—revealed systematic failures in the Foreign Supplier Verification Program (FSVP), the regulatory framework governing how U.S. importers verify that foreign suppliers meet American food safety standards.
**Regulatory Citations and Context**
The violations center on 21 CFR Part 1, Subpart L, implementing Section 805 of the Federal Food, Drug, and Cosmetic Act. These requirements mandate that importers develop, maintain, and follow documented FSVP protocols specific to each foreign supplier and product. The regulations require risk-based verification activities—not one-size-fits-all compliance. Balkanica's failure was foundational: the company had not developed FSVP documentation for the listed suppliers at all. The FDA's June 4 response from Balkanica indicated a newly retained qualified individual was only in "initial stages" of document collection, demonstrating the violations persisted across multiple inspection cycles.
**Timeline and Industry Monitoring**
Balkanica received 15 working days to respond with corrective action documentation. FDA signaled potential enforcement escalation: detention without physical examination (DWPE) under Import Alert #99-41 and refusal of admission under Section 801(a)(3). Compliance officers in food import should monitor whether Balkanica submits adequate FSVP documentation within the deadline, as inadequate responses typically precede import holds or regulatory action against repeat violators.
Severity context
Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
Regulatory background
FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER Balkanica LLC MARCS-CMS 732478 — June 29, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Product: Food & Beverages Recipient: Recipient Name Martin Karaivanov Recipient Title Managing Partner Balkanica LLC 2 Ackerman Ave Clifton , NJ 07011-1502 United States MARTIN@BALKANICA.US Issuing Office: Office of Inspections and Investigations United States WARNING LETTER RE: CMS# 732478 Dear Mr. Martin Karaivanov: On May 20, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of Balkanica LLC., located at 2 Ackerman Ave, Clifton, NJ 07011-1502. We also conducted inspections on July 31, 2023, and October 24, 2024. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L. The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals. During the most recent inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods from the foreign suppliers indicated in the attached list. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We acknowledge receipt of your response, dated June 4, 2026, in which you provided a letter from (b)(4) , which stated that they have been acting as your qualified individual beginning on (b)(4) . The letter also stated that they were “in the initial stages of document collection and FSVP evaluations.” On the same letter, they provided a corrective action plan with a proposed schedule of completion of (b)(4) for one correction, and the remaining to be completed by (b)(4) . We are unable to evaluate the adequacy of your response because you have not provided any supporting documentation demonstrating your corrective actions. To date, no additional FSVP documents have been received by FDA. Your significant violations of the FSVP regulation are as follows: You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for the foods you import from the foreign suppliers indicated in the attached list, including each of the following foods: Sunflower Seeds, imported fr…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What is the regulatory background for a Warning Letter warning letter?
- FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- Has Balkanica LLC had FDA enforcement actions before?
- This is the only FDA Warning Letter Argus HQ has on file for Balkanica LLC as of 2026-07-21. Argus ingests new FDA enforcement records daily.
- What FDA violations was Balkanica LLC cited for?
- The FDA Warning Letter to Balkanica LLC (issuing office: Office of Inspections and Investigations) cites: Foreign Supplier Verification Program (FSVP). Classification: Warning Letter.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Warning Letter to Balkanica LLC (2026-06-29) — Foreign Supplier Verification Program (FSVP). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-balkanica-llc-2026-06-29-warning-letter
"FDA Warning Letter to Balkanica LLC (2026-06-29) — Foreign Supplier Verification Program (FSVP)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-balkanica-llc-2026-06-29-warning-letter.
Argus HQ Research. "FDA Warning Letter to Balkanica LLC (2026-06-29) — Foreign Supplier Verification Program (FSVP)." Digital Empire Holdings LLC. Accessed July 24, 2026. https://argushq.ai/fda/warning-letter/fda-wl-balkanica-llc-2026-06-29-warning-letter.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_balkanica_llc_2026_06_29_warning_letter_2026,
title = {FDA Warning Letter to Balkanica LLC (2026-06-29) — Foreign Supplier Verification Program (FSVP)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-balkanica-llc-2026-06-29-warning-letter},
note = {Accessed: July 24, 2026}
}